Which hedge funds own NRXP? NRX PHARMACEUTICALS INC, Q2 2026 13F holders

10 tracked hedge funds disclosed a position in NRXP (NRX PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $24.5m in total. The largest holder by portfolio weight is B Group, Inc. at 9.5% of its book. 9 opened a new position this quarter: Persistent Asset Partners Ltd, Balyasny Asset Management L.P., Citadel Advisors LLC, ExodusPoint Capital Management, LP. 1 exited: Schonfeld Strategic Advisors LLC.

10

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

9

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

1

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$7.7m

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$42.3k

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$24.5m

Combined value

Sum of the holders' reported positions in the security.

0.8%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.